The purpose of the study is to obtain initial efficacy and safety data on tailored-dosing tobramycin for the treatment of pulmonary exacerbations associated with Pseudomonas aeruginosa in patients with cystic fibrosis. Larger scale, multicenter, collaborative trial are planned to incorporate these pilot data.
Showing the most recent 10 out of 782 publications